NTT-DATA
26.2.2024 06:02:29 CET | Business Wire | Press release
NTT DATA, a global leader in IT infrastructure and services, and Schneider Electric, a pioneer in digital transformation for energy management and automation, have unveiled a first-of-a-kind co-innovation that empowers enterprises to harness the power of edge computing. The strategic partnership introduces a unique solution that seamlessly integrates Edge, Private 5G, IOT, and Modular Data Centers, providing unparalleled connectivity, and supports the computational demands of Generative AI applications deployed at the edge.
The joint offering combines NTT DATA’s Edge as a Service, which includes fully managed Edge to Cloud, Private 5G, and IoT capabilities, with Schneider Electric’s EcoStruxure, a modular data center that fuses OT solutions with the latest in IT technologies. This powerful combination enables companies to maximize energy efficiency and meet the demands of compute-intensive tasks such as machine vision, predictive maintenance, and other AI inferencing applications at the edge.
“We've listened to our customers and know that processing vast amounts of data generated by edge devices is where the future of digital transformation lies. That's why we're excited to announce that we have the solution to meet these obstacles and are ready to lead the way towards a more connected and efficient digital world. We are thrilled at the prospect of what our continued collaboration with Schneider Electric means for the industrial and other sectors,” said Shahid Ahmed, EVP New Ventures, and Innovation at NTT Ltd.
Customers can now implement a complete solution, including edge data centers tailored for digital transformation in remote and brownfield locations, where high compute demands critical infrastructure, such as power, cooling, racks, and specialized IoT and AI management systems.
The companies will go to market to address joint customer requirements to meet the growing demand from organizations who are looking to leverage edge compute to support automation and enable data-driven decision making. According to NTT DATA’s Edge Advantage report nearly 70% of enterprises are accelerating edge adoption to solve critical business challenges.
With today’s news, NTT DATA and Schneider Electric announced they are delivering the first Private 5G enabled deployment of an EcoStruxure Data Center at Marienpark Berlin. The historic site will be developed into a leading innovation park. The area spans over 30-hectare, equivalent to 74 acres, and will focus on delivering enhanced connectivity and compute experiences for users across the campus.
“Today’s innovation ecosystems in Marienpark increasingly depend on specific technological infrastructures. Easy-to-access computational power combined with advanced connectivity are a key issue. We need an innovative environment with such an infrastructure to satisfy future user demands of our community,” said Guido Schütte, Managing Director, Marienpark Berlin.
NTT DATA and Schneider Electric initially co-innovated to test the power of Private 5G at Schneider Electric’s Lexington Smart Factory, the first of Schneider Electric’s U.S. plants to become a Smart Factory showcase site leveraging Private 5G, IoT connectivity, edge analytics, and predictive analytics to drive energy efficiency and further sustainability goals.
“After leveraging NTT DATA’s expertise in Private 5G connectivity and then maximizing synergies with our EcoStruxure architecture in our facilities, it’s time to expand our collaboration and bring a complete solution to industrial customers,” said Rob McKernan, President, Cloud & Service Provider Segment at Schneider Electric. “Together, we aim to assist global clients in adopting connected devices, specialized industrial solutions, and the right edge computing infrastructure with modular Data Centers to gain valuable data insights, particularly in the context of IoT and emerging AI requirements.”
The collaboration addresses the challenges brought on by industry 4.0 applications, ensuring seamless connectivity, high bandwidth, and secure low latency connections through Edge data centers.
“Industry 4.0 relies on actionable, data-driven intelligence delivered in real time whether that be in a factory, an industrial park, an airport, or an office campus,“ said Camille Mendler, Chief Analyst, Enterprise Services, Omdia. “AI-enriched data already accounts for a third of enterprise network traffic, but it will dominate digital interactions by 2030. To profit from AI insights, enterprises must invest in digital resources at the edge, and the technology infrastructure that powers it, now.”
Innovations on Display at Mobile World Congress
NTT DATA and Schneider Electric will discuss their co-innovation partnership and demonstrate how edge and private 5G are transforming industries on February 26 between 1300 – 1400 hours at the NTT DATA booth in Hall 4 – Stand 4A20.
About NTT Ltd.
As part of NTT DATA, a USD 30 billion IT services provider, NTT Ltd. is a leading IT infrastructure and services company serving 65% of the Fortune Global 500 and more than 75% of the Fortune Global 100. We lay the foundation for organizations’ edge-to-cloud networking ecosystem, simplify the complexity of their workloads across multicloud environments, and innovate at the edge of their IT environments where networks, cloud and applications converge. We offer tailored infrastructure and ensure consistent best practices in design and operations across all of our secure, scalable and customizable data centers. On the journey towards a software-defined future, we support organizations with our platform-delivered infrastructure services. We enable a connected future.
Visit us at services.global.ntt
About Schneider Electric
Schneider Electric’s purpose is to empower all to make the most of our energy and resources, bridging progress and sustainability for all. We call this Life Is On. Our mission is to be your digital partner for Sustainability and Efficiency. We drive digital transformation by integrating world-leading process and energy technologies, end-point to cloud connecting products, controls, software and services, across the entire lifecycle, enabling integrated company management, for homes, buildings, data centers, infrastructure and industries. We are the most local of global companies. We are advocates of open standards and partnership ecosystems that are passionate about our shared Meaningful Purpose, Inclusive and Empowered values. www.se.com
Follow us on:
X
Facebook
LinkedIn
YouTube
Instagram
Schneider Electric Blog
Discover the newest perspectives shaping sustainability, electricity 4.0, and next-generation automation on Schneider Electric Insights.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240223446791/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Barilla Opens Global Call for Startups Through Good Food Makers 202625.5.2026 11:47:00 CEST | Press release
The program has involved over 1,100 startups across 50+ countries, delivering 26 pilot projects. Barilla Group has opened applications for the 2026 edition of Good Food Makers, its global open innovation program designed to co-develop and test new innovative solutions with startups and innovators inside real industrial environments. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260521973445/en/ Since its launch in 2019, the program has involved more than 1,100 startups from over 50 countries, leading to 26 pilot projects, with over 20 projects currently active thanks to the solutions developed by the program’s alumni. This highlights the program’s role as a concrete platform for industrial scalable innovation. The 2026 edition comes at a pivotal moment for the company, following the launch of BITE (Barilla Innovation & Technology Experience), the new innovation center dedicated to developing the next generation of food prod
JEOL: Sales Launch of the Laser SEM System “LazEdge”25.5.2026 10:16:00 CEST | Press release
JEOL Ltd. (President & CEO: Izumi Oi) has developed the “LazEdge”, an SEM system equipped with a laser processing system, and begins sales on May 25, 2026. Cross-section preparation instruments such as the focused ion beam system (FIB system), are widely used in science and technology fields across research institutes, universities, and industries. In recent years, demand is increasing for a system that can process large-areas at a high speed, while achieving high-quality of the processed surface. “LazEdge” is an instrument integrating JEOL’s SEM with the laser technology proprietary of Hamamatsu Photonics K.K., and enables laser processing inside the specimen chamber of the electron microscope. This system enables high-quality cross-section specimens produced through high-speed, large-area processing to be transferred seamlessly to subsequent analyses, such as SEM observation, elemental analysis, and crystal orientation analysis, without exposure to the external environment. As a resu
TFG-001, A Novel 3D Neural Microtissue Cell Therapy, Demonstrates Superior Functionality and Reinnervation for Parkinson’s Disease25.5.2026 08:00:00 CEST | Press release
TreeFrog Therapeutics, a regenerative medicine biotech company developing next-generation cell therapies, today announced that it will present new preclinical data on TFG-001 at the 7th World Parkinson’s Conference. TFG-001, a 3D neural microtissue cell therapy, demonstrated rapid dopamine release and extensive graft-derived reinnervation across multiple advanced translational Parkinson’s disease models—supporting its potential as a best-in-class candidate. The critical need for reinnervation in Parkinson's disease In Parkinson's disease, an estimated 60–80% of dopaminergic neurons are already lost before motor symptoms even appear. The nigrostriatal pathway degenerates, destroying the essential wiring that connects dopamine-producing neurons to movement control. While chemical dopamine replacements (like levodopa) can manage symptoms, they cannot restore the spatial precision, feedback loops, or dynamic regulation of a healthy brain network. To achieve true functional restoration, it
Galderma Receives U.S. FDA Approval for Differin® Epiduo® Acne Gel Prescription-to-OTC Switch22.5.2026 18:25:00 CEST | Press release
A unique Prescription-to-OTC switch in acne care, this approval expands access to a dermatologist-trusted, prescription-strength treatment for millions of acne sufferers ages 12 years and older Backed by more than 15 years of real-world dermatologist use and a robust clinical research program, this milestone demonstrates the depth of science behind the Differin® and Epiduo® heritage Adapalene plus benzoyl peroxide (0.1/2.5%) was the first FDA-approved, stable, fixed- dose prescription acne treatment to combine of benzoyl peroxide with a retinoid, and is now available over-the-counter The formulation is engineered to target multiple causes of acne more effectively than either of its individual active ingredients alone Galderma (SIX: GALD), the pure-play dermatology category leader, today announced that the United States (U.S.) Food and Drug Administration (FDA) has approved Differin® Epiduo® Acne Gel (Adapalene 0.1% and Benzoyl Peroxide 2.5% Acne Treatment) for over-the-counter (OTC) us
Avanzanite Bioscience’s Partner Agios Announces PYRUKYND® (mitapivat) Approval in the European Union for Adults with Thalassaemia22.5.2026 16:18:00 CEST | Press release
Avanzanite will commercialise and distribute PYRUKYND in Europe under its exclusive agreement with Agios Avanzanite is committed to collaborating with local authorities in the EU to enable access to PYRUKYND for adult patients with thalassaemia Avanzanite Bioscience B.V., a rapidly growing commercial-stage European specialty pharmaceutical company focused on rare diseases, today reported that its partner, Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a commercial-stage biopharmaceutical company headquartered in Cambridge, Massachusetts focused on delivering innovative medicines for patients with rare diseases, announced that the European Commission has granted marketing authorisation for PYRUKYND® (mitapivat), an oral pyruvate kinase (PK) activator, in adults for the treatment of anaemia associated with transfusion-dependent and non-transfusion-dependent alpha- or beta-thalassaemia, with an orphan medicinal product designation. This press release features multimedia. View the full releas
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom